Golforoush, Pelin A.
Narasimhan, Priyanka
Chaves-Guerrero, Patricia P.
Lawrence, Elsa
Newton, Gary
Yan, Robert
Harding, Sian E.
Perrior, Trevor
Chapman, Kathryn L.
Schneider, Michael D.
Funding for this research was provided by:
Wellcome Trust (WT10638)
British Heart Foundation (RM/13/1/30157)
Article History
Received: 4 December 2019
Accepted: 25 June 2020
First Online: 21 July 2020
Competing interests
: MDS declares patent applications relating to MAP4K4 as a druggable target in human cardiac muscle cell death (UK Patent Applications 1716867.5, WO/2019/073253; 1819839.0, WO/2020/115481). The remaining authors declare no competing interests.